Randy Ban - Jan 3, 2023 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role
Chief Commercial Officer
Signature
/s/ Bryan Phillips, as Attorney-in-Fact for Randy Ban
Stock symbol
INSP
Transactions as of
Jan 3, 2023
Transactions value $
-$2,511,553
Form type
4
Date filed
1/5/2023, 06:01 PM
Previous filing
Dec 6, 2022
Next filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSP Common Stock Options Exercise $9.4K +10K +3289.47% $0.94* 10.3K Jan 3, 2023 Direct F1
transaction INSP Common Stock Sale -$601K -2.4K -23.29% $250.62 7.9K Jan 3, 2023 Direct F2, F3, F4
transaction INSP Common Stock Sale -$654K -2.6K -32.89% $251.64 5.3K Jan 3, 2023 Direct F2, F4, F5
transaction INSP Common Stock Sale -$957K -3.79K -71.42% $252.71 1.52K Jan 3, 2023 Direct F2, F4, F6
transaction INSP Common Stock Sale -$268K -1.06K -69.66% $253.79 460 Jan 3, 2023 Direct F2, F4, F7
transaction INSP Common Stock Sale -$39.9K -156 -33.91% $255.98 304 Jan 3, 2023 Direct F2, F4, F8
holding INSP Common Stock 167 Jan 3, 2023 By son
holding INSP Common Stock 166 Jan 3, 2023 By daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -10K -32.16% $0.00 21.1K Jan 3, 2023 Common Stock 10K $0.94 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 19 additional shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on December 6, 2022.
F2 The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.09 to $251.05, inclusive.
F4 The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.22 to $252.15, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.26 to $253.16, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.41 to $254.2966, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.97 to $256.00, inclusive.
F9 The option is fully vested and exercisable.